Product/Composition:- | Cephalexin Powder for Suspension |
---|---|
Strength:- | 125 mg/5 mL, 250 mg/5 mL, 500 mg/5 mL |
Form:- | Powder for Suspension |
Reference Brands:- | Keflex(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Cephalexin suspension inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis. It treats respiratory, skin, and urinary infections effectively. Benefits include rapid, targeted therapy, suitability for pediatric use, oral convenience, and broad-spectrum activity, making it a reliable option for managing common bacterial infections.
Cephalexin suspension is approved in the EU and US for pediatric and adult bacterial infections, including respiratory and urinary tract infections. In the EU, brands like Keflex are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data, with many generics available. Both regions require comprehensive dossiers, including clinical trial results, production standards, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for cephalexin suspension, ensuring adherence to European and American standards for safe, effective antibiotic therapy.